Novartis — full event log
Every event we have on file across every reporting year. The Data-by-year tab summarises the top 10 per year; this page shows them all.
← back to Data by year2024· 18 events
Downstream transportation emissions rose to 111.3 ktCO2e in 2024 (vs 77.2 in 2023), driven by growth in product volumes. Upstream transport at 166 ktCO2e. Engaging with logistics suppliers as part of broader Scope 3 supplier engagement program.
sustainability_report p.61
Near- and long-term targets approved by SBTi: 90% reduction in Scope 1 and 2 by 2030, 42% Scope 3 by 2030, all scopes 90% by 2040 vs 2022 base year.
sustainability_report p.25
Target to be carbon neutral in Scope 1 and 2 from energy by 2025 using high-quality biomethane certificates and nature-based carbon removals.
sustainability_report p.26
Committed to 100% renewable electricity across operations by 2025 (RE100) and transitioning fleet to electric vehicles by 2030 (EV100).
sustainability_report p.25
New target: no water quality impacts from manufacturing effluents by 2030 covering all own sites and all API suppliers; existing 2025 target already on track.
sustainability_report p.31
By end of 2024, eliminated 100% of PVC in packaging at all 24 manufacturing sites handling final product packaging, achieving the 2025 target.
sustainability_report p.31
New target to reduce waste sent for disposal by 30% by 2030 from a 2022 baseline; 2025 target already achieved (-72% vs 2016).
sustainability_report p.31
Conducted nature assessment for own operations and upstream supply chain aligned with TNFD LEAP framework; assessing biodiversity to complement water and waste pillars.
sustainability_report p.30
Definition for water consumption changed to align with GRI standards. Previously water discharged via treatment was included in water consumption; now classified as water discharged. 2022/2023 figures revised.
sustainability_report p.61
2016 baseline for environmental targets restated to remove Sandoz following spin-off.
sustainability_report p.3
Strategic acquisitions to strengthen oncology pipeline including pelabresib (myelofibrosis) from MorphoSys.
sustainability_report p.48
95% of emissions are Scope 3 (outside own operations). Embedding environmental sustainability criteria into procurement: contracts with such criteria now cover 76% of Scope 3 emissions (up 19ppts YoY), targeting 100% by 2025. Engaged with suppliers covering >two-thirds of Scope 3 emissions. Launched Environmental Sustainability Supplier Playbook shared with 1,000+ suppliers and integrated into PSCI standard learning plans. Participating in Energize initiative for supplier renewable energy procurement.
sustainability_report p.28
Systematically integrating LCA methods in R&D pipeline to calculate and improve environmental impact of products. Implemented measures to reduce waste and emissions from clinical trials. Obtained My Green Lab certification for 96% of laboratories in technical R&D.
sustainability_report p.26
KPMG AG provided limited assurance per ISAE 3000 (Revised) and ISAE 3410 on selected sustainability performance indicators.
sustainability_report p.72
Committed to RE100: 100% renewable electricity across operations by 2025. In 2024, 96% of purchased electricity was renewable (up from 92% in 2023). Already at 100% renewable electricity in North America (US and Canada) and Europe through virtual power purchase agreements. Expanded renewable sourcing to sites in Asia and South America in 2024. Also participating in Energize industry initiative with Schneider Electric to facilitate renewable electricity procurement for suppliers.
sustainability_report p.28
Primary focus is on absolute emission reductions. For 2025 carbon neutrality target in own operations (Scope 1+2 from energy), plan to neutralize residual emissions using a mix of high-quality biomethane certificates and nature-based carbon removal solutions. For 2040 net-zero, will invest in high-quality carbon removals to neutralize unavoidable emissions (<10% of 2022 base year), in line with SBTi Corporate Net-Zero Standard. Stress-tested offsets outlook using BNEF voluntary market scenario, BECCS and direct air capture forecasts.
sustainability_report p.26
Deployed USD 40 million capital expenditure in 2024 on environmental projects to improve energy efficiency, adopt renewable energy solutions, and reduce natural resource consumption. Activities led to 20% reduction in Scope 1+2 emissions YoY and 71% vs 2016 baseline. Initiatives include optimizing HVAC, upgrading to energy-efficient equipment, and improved building insulation.
sustainability_report p.27
Transitioning vehicle fleet to electric vehicles by 2030 in line with EV100 commitment, where technically feasible based on availability of public charging, home charging feasibility, and OEM/EV model availability per market.
sustainability_report p.25
2023· 2 events
Renewed Equal Pay International Coalition pledge with goals to maintain gender-balanced management, eliminate bias from HR practices, and adopt EU Pay Transparency Directive as global minimum standard by 2027.
sustainability_report p.35
Novartis spun off its generics and biosimilars business Sandoz in 2023; 2024 is first full year as pure-play medicines company. 2016 environmental baseline restated to remove Sandoz.
sustainability_report p.3